In the current study, BCG was expressly chosen as a treatment for its induction of TNF, which has been shown to play a therapeutic role in at least in four rodent models of five autoimmune diseases [3], [7], [8], [10], [12], [29], [30] and in vitro[4]. This evidence concerns the gene TNF and autoimmune disease.